• Occidental College, Los Angeles CA 1966-1970; B.A., Economics

• University of California, Irvine CA 1975-1977, B.S., Biology

• UCLA School of Medicine, Los Angeles CA 1977-1981, M.D.

• Harbor-UCLA Medical Center, Torrance CA 1981-1986, Obstetrics and Gynecology Internship and Residency

• American Board of Obstetrics and Gynecology, 1990-present

• State of California Medical Board

• Physician and Surgeon, California, 1981-present

• Physician Assistant Supervisor, California, 1985-2001

• Medical Director, Women’s Health Care Community Education and Research Program, Los Angeles BioMedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, 2014-present.

• Medical Director, Research Division, California Family Health Council (CFHC), Los Angeles CA 1995-present.

• Program Director, Women’s Health Care Teams and Consulting Gynecologist, Coastal County Health Centers, Los Angeles County Department of Health Services, 1996-2013

• Medical Director, Women's Health Care Clinic, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance CA 1985-2014.

• Medical Director, Women's Health Care Nurse Practitioner Education Programs, Los Angeles Biomedi cal Research Institute at Harbor-UCLA Medical Center, Torrance CA 1985-2013.

• OB-GYN Third-Year Medical Student Clerkship Director, Harbor-UCLA Medical Center, 2004-2014

• Medical Director, Women, Infants and Children (WIC) Program, South Area, County of Los Angeles, 1985-2001.

• Professor Emeritus, Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles 2015 to present.

• Professor Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 1999-2015.

• Reproductive & Women’s Health

• Women’s Health & Contraception

• Impact of injectable contraceptive (DMPA) on weight of new start users over time Project No. 13026-01 (PI)

• Bleeding and continuation rates of progestin-only pills vs combined birth control pills (PI with resident Ceyela, Mayorquine, Lynn)

• Natural history of glucose intolerance and metabolic syndrome in women following pregnancy with gestational diabetes (PI with resident Neetu)

• Survey of English speaking family planning patients about reproductive life plans (PI with Shabaik S, Xandre, Avila)

• A phase IIb randomized, double blind, comparative study to assess the efficacy, safety, tolerability and inhibition of ovulation of two continual regimens of oral daily 5mg or 10 mg of ulipristal acetate (UPA), versus a dose of 5.0mg UPA for 24/4 daily (PI)

• Pharmacokinetics of the levonorgestrel-only emergency contraceptive regimen in normal-weight and extremely obese users: a pilot study (Co-investigator. PI Natavio L)

• A single-arm, open label multicenter Phase 3 study of contraceptive efficacy, safety, and tolerability of the AG200-15 transdermal contraceptive delivery system (co-PI with Fung Lam)

• 2010 List of Southern California Super Doctors, Los Angeles Biomedical Research Institute, January 2010

• Accepted Kate Stevens Community Service Award for the Women’s Health Care Clinic, April 2011

• 2011 List of Southern California Super Doctors, Los Angeles Biomedical Research Institute, June 2011

• Family Planning Champion 2012 California Family Health Council. March 2012

• Excellence in Education, David Geffen School of Medicine, 2012

• President’s guest speakers, Miami OB-GYN Society, March 2013

• Silver Knight Award, National Management Association, Harbor UCLA Chapter, June 2013

• James Platt White Memorial Lecturer, Buffalo OB-GYN Society, April 2014

• Distinguished Physician Award, Southern California OB-GYN Assembly, May 2014

• Certificate of appreciation, Immunize LA Families, June 2015

• Certificate of Appreciation, The Thai Nurses Association of Southern California, August, 2015

• The American College of Obstetricians and Gynecologists (ACOG)

• Pacific Coast Obstetrics and Gynecology Society

• Obstetrical and Gynecological Assembly of Southern California

• Chair, Harbor-UCLA Medical Center Continuing Medical Education Committee

• Chairman, Women’s Health Care Protocol Committee; Women's Health Care Programs, Harbor-UCLA Medical Center

• Mentor, Problem Based Learning, second year medical students, UCLA

• Member, Southern California Family Planning Consortium, Los Angeles

• DHS/DPH Reproductive Health Workgroup

• Women in Medicine, Torrance, CA

• Member, Board of Directors, Los Angeles Trust for Children’s Health

Peer Reviewed Journals

• Bitzer J, Heikinheimo O, Nelson A , Fraser IS, Calif-Alsina J. Medical Management of Heavy Menstrual Bleeding: A systematic Review of the Literature. Obstetrical & Gynecological Survey 2015;70(2):115-30.

• Aiken, A, Creinin MD, Kaunitz AM, Nelson AL , Trussell J. Gobal Fee Prohibits Postpartum Provision of the Most Effective Reversible Contraceptives. Contraception . 2014;90(5):466-7.

• Gemzell-Danielsson K, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K, Nelson A . A Multicentre, randomized phase III study of two low-dose levonorgestrel intrauterine contraceptive systems: Subgroup analyses evaluating efficacy, safety, placement, and user satisfaction according to age and parity. PloS One. 2015;10(9):e0135309.

• Nelson AL. Prenatal Counselling and Postpartum Method Provision. Open Access Journal of Contraception 2015;6:53-64.

• Nelson AL, Papa R, Ritchie J. Asymptomatic Cervical Polyps: Can we just let them be? Women’s Health Future Medicine 2015;11(2):121-126.

• Nelson, AL Transdermal contraception methods: today’s patches and new options on the horizon, Expert Opin. Pharmacother. 2015;16(6):863-73

• Rosen T, Nelson A , Ault K. Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men. Cutis . 2015;96(4):277-82.

• Nelson AL, Ritchie JJ. Severe anemia from heavy menstrual bleeding requires heightened attention. Am J Obstet Gynecol. 2015;213(1):97.e1-6.

• Gemzell-Danielsson K, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K, Nelson A. The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated with Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial. PLoS One . 2015;10(9):e0135309

• Nelson AL. An update on new orally administered contraceptives for women. Expert Opin Pharmacother. 2015;16(18):2759-72

• Nelson AL. Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development. Expert Opin Investig Drugs . 2015;24(10):1321-30.

• Goldsmith C, Nelson AL Urgent need to change clinical practices around postpartum contraception. World ObstetGynecol. 2015;4(3):52-57.

• Xandre P. Shabaik S, Nelson AL Reproductive Life Plans of Spanish Speaking Women. Womens’s Healthcare. www.NPWomensHEALTHCARE.com November 2015;2(2):1-4

• Nelson AL, Kakaiya R. Prevention of Unintended Pregnancy among Sexually Active Adolescents in the United States. Primary Prevention Insights . 2016;6:1-10.